Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases. - Chen MF; Lee JJ; Choudhury NJ; Hui AB; Jeng MY; Zheng J; Aly RG; Sielski N; Ahn L; Pupo A; Nesselbush MC; Jabara I; et al. (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2026)